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Abstract
Cocoa can be a rich source of antioxidants including the flavan-3-ols, epicatechin and catechin, and their oligomers
(procyanidins). While these flavonoids have been reported to reduce the rate of free radical-induced erythrocyte hemolysis in
experimental animal models, little is known about their effect on human erythrocyte hemolysis. The major objective of this
work was to study the effect of a flavonoid-rich cocoa beverage on the resistance of human erythrocytes to oxidative stress.
A second objective was to assess the effects of select purified cocoa flavonoids, epicatechin, catechin, the procyanidin Dimer
B2 and one of its major metabolites, 30-O-methyl epicatechin, on free radical-induced erythrocyte hemolysis in vitro.
Peripheral blood was obtained from 8 healthy subjects before and 1, 2, 4 and 8 h after consuming a flavonoid-rich cocoa
beverage that provided 0.25 g/kg body weight (BW), 0.375 or 0.50 g/kg BW of cocoa. Plasma flavanol and dimer
concentrations were determined for each subject. Erythrocyte hemolysis was evaluated using a controlled peroxidation
reaction. Epicatechin, catechin, 30-O-methyl epicatechin and (-)-epicatechin-(4b . 8)-epicatechin (Dimer B2) were detected
in the plasma within 1 h after the consumption of the beverage. The susceptibility of erythrocytes to hemolysis was reduced
significantly following the consumption of the beverages. The duration of the lag time, which reflects the capacity of cells to
buffer free radicals, was increased. Consistent with the above, the purified flavonoids, epicatechin, catechin, Dimer B2 and the
metabolite 30-O-methyl epicatechin, exhibited dose-dependent protection against AAPH-induced erythrocyte hemolysis at
concentrations ranging from 2.5 to 20mM. Erythrocytes from subjects consuming flavonoid-rich cocoa show reduced
susceptibility to free radical-induced hemolysis ðp , 0:05Þ.
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Introduction
Flavonoids are a diverse group of polyphenolic
compounds occurring in fruit, vegetables, tea and
red wine. Diets rich in these compounds have been
associated with a reduced risk for cardiovascular
disease (Knekt et al. 2002, Kris-Etherton et al. 2004,
Mennen et al. 2004, Morton et al. 2000, Sagara et al.
2004, Sesso et al. 2003). Depending on their
processing, cocoa and chocolate can be rich sources
of flavonoids, particularly the subclass of oligomeric
flavonoids known as procyanidins (Adamson et al.
1999, Sanchez-Rabaneda et al. 2003, Steinberg et al.
2003) (Figure 1). Flavanols and procyanidins isolated
from cocoa and chocolate have received considerable
attention over the last several years as potential
cardiovascular protective agents with putative positive
effects on platelet function, blood pressure regulation,
nitric oxide production, oxidative defense and the
immune system (Heiss et al. 2003, Maron, 2004;
Fisher et al. 2003; Pearson et al. 2002, Sadik et al.
2003, Taubert et al. 2003, Wan et al. 2001).
ISSN 1740-2522 print/ISSN 1740-2530 online q 2005 Taylor & Francis Group Ltd.
DOI: 10.1080/17402520512331329514
Correspondence: Carl L. Keen, Department of Nutrition, University of California, One Shields Avenue, Davis, CA 95616-8669.
Tel: 1 530 752 6331. Fax: 1 530 752 8966. E-mail: clkeen@ucdavis.edu
Clinical & Developmental Immunology, March 2005; 12(1): 27–34
These compounds can modulate the actions of
oxidant-responsive transcription factor NF-kB
(Mackenzie et al. 2004), and diets rich in cocoa
flavonoids may be associated with reductions in DNA
oxidative damage (Orozco et al. 2003).
Excessive oxidative damage to cellular membranes
may contribute to the development of many degene-
rative diseases, including certain cancers and cardiovas-
cular diseases (Cooke et al. 2003, Hensley et al. 2000,
Kris-Etherton et al. 2004, Morena et al. 2000, Morton
et al. 2000). Erythrocytes are especially susceptible to
oxidation due to their high content of polyunsaturated
lipids, their rich oxygen supply and the presence of
transition metals such as iron and copper (Delmas-
Beauvieux et al. 1995, Mennen et al. 2004). Reactive
oxygen species (ROS) generated in the plasma, cytosol,
or cell membrane can attack erythrocyte membranes,
compromise their integrity, and induce the
oxidation of lipids and protein resulting in hemolysis
(Bracci et al. 2002, Chan et al. 1999, Delmas-Beauvieux
et al. 1995, Niki et al. 1988). Given their function, and
their susceptibility to oxidative damage, investigators
have used erythrocytes, and free radical initiators such as
2,20-azo-bis (2-amidinopropane) dihydrochloride
(AAPH) and UVB as models for studying biomembrane
oxidative damage (Carini et al. 2000, Chan et al. 1999,
Liu et al. 2002, Mabile et al. 2001, Niki et al. 1988, Zhu
et al. 2002). We recently studied the inhibitory effects of
flavanoid-rich cocoa extract on rat erythrocyte hemo-
lysis, and found that hemolysis resistance was enhanced
following the feedingof thisextract ðp , 0:05Þ (Zhuetal.
2002). While these results are provocative, the
differences in flavonoid metabolism between rats and
humans (Natsume et al. 2003), and the fact that an
extract rather than a food per se was used in the above
study preclude a direct extrapolation of these results to
humans.
In the present work, we evaluated the effects of a
flavanol-rich cocoa on the susceptibility of human
erythrocytes to hemolysis. We also assessed the ability
of select purified cocoa flavonoids (epicatechin and
catechin, Dimer B2), and one of the major metabolites
of epicatechin, 30-O-methyl epicatechin, to protect
against human erythrocyte hemolysis, in vitro.
Subjects and methods
Subjects and clinical study design
Eight healthy adult male subjects were recruited from
the general population at the University of California
at Davis. All subjects signed informed consent forms
prior to the study in accordance with the guidelines of
the Human Subjects Review Committee of the
University of California, Davis.
In a cross-over study design, the subjects consumed
a low polyphenolic control meal of bread and water
(1.5 g/kg and 10 ml/kg subject body weight, respect-
ively), followed by a low [0.25 g/kg body weight
(BW)], medium (0.375 g/kg BW), or high flavonoid-
rich cocoa beverage (0.50 g/kg BW), with a one week
washout period between doses. One gram of the
cocoa provided 12.2 mg monomers (epicatechin and
catechin), 9.7 mg dimers (consisting of two monomer
units) and 28.2 mg of the longer procyanidins (trimers
through decamers built upon monomer units).
Figure 1. Chemical structures of (A) monomer and procyanidin oligomers, n ¼ 1 (monomer), 2 (dimer) to 10 (decamer); (B) 30-O-methyl
epicatechin; (C) Dimer B2 (epicatechin-(4b . 8)-epicatechin.
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The mean age of the subjects was 26 ^ 2 y (range:
19–31), the mean body weight was 79:1 ^ 5:7 kg; the
average height was 1:80 ^ 0:05 m and the mean body
mass index (in kg/m2) was 24 ^ 1. All subjects were
apparently healthy.
Onthe day before the experiment, subjectswere asked
to refrain from consuming phenolic-rich foods (e.g. tea,
wine, fruits and vegetables). They were asked to fast
(no food or drink, except water) for approximately 10 h
prior to the experiment. On the day of the study, blood
was drawn by venipuncture to establish baseline values.
Within 15 min after the baseline blood draw, subjects
were given bread [1.5 g/kg BW] and water (10 ml/kg
BW) in the first visit (week 1). Venous blood samples
were then obtained at 1, 2, 4 and 8 h after the initial
baseline draw. Blood was drawn into evacuated tubes
containing sodium heparin as an anticoagulant, and the
plasma was then separated by low-speed centrifugation
(3,000 £ g) at48C for10 min,and storedat2808C until
further analysis. Weeks 2, 3 and 4 were the same except
for doses of cocoa: subjects received 0.250 g/kg BW
cocoa at week 2, 0.375 g/kg BWat week 3 and 0.50 g/kg
BWat week 4 (Cocoapro; Mars Inc, Hackettstown, NJ).
Erythrocytes hemolysis
Immediately after the blood draw, erythrocytes were
separated from the plasma and buffy coat by
centrifugation at 3,000 £ g for 10 min. The crude
erythrocytes were washed three times with 5 vol of
phosphate buffered saline, pH ¼ 7:4 (PBS, GIBCO
BRL, Invitrogen Life Technologies, Carlsbad, CA).
During the last wash, the erythrocytes were centri-
fuged at 3,000 £ g for 20 min to obtain a packed cell
preparation. The packed erythrocytes were then
suspended in 4 vol of PBS solution.
The method of Miki et al. (1987) was used to
determine radical mediated hemolysis, with minor
modifications (Zhu et al. 2002). Briefly, washed
erythrocytes were resuspended in PBS at 10%
hematocrit, and after the addition of 200 mM AAPH
(1:1), the reaction mixture was incubated at 378C.
Samples of the reaction mixture were obtained and
centrifuged every 20 min. The supernatant fraction
was then discarded, and the pellet lysed with 3 ml of
distilled water. Hemoglobin concentration in the
supernatant fraction after centrifugation was deter-
mined by measuring the absorbance at 540 nm.
Erythrocytes incubated without AAPH and treated
similarly were used to measure the total hemoglobin
content of the cells. The percentage of hemolysis
induced by AAPH was calculated by the equation:
%Hemolysis ¼ ½12 Asample=Atotal £ 100 ð1Þ
Where: Asample is the absorbance of the test sample
collected every 20 min from the reaction mixture, and
Atotal is the total hemoglobin content of the cells.
In vitro study of epicatechin, catechin, Dimer B2 and
3 0-O-methyl epicatechin
Epicatechin, catechinandDimerB2purified fromcocoa
were provided by Mars Incorporated (CocoaproTM,
Hackettstown, NJ) (Adamson et al. 1999). The 30-O-
methylated conjugate of epicatechin (Figure 1B) was
synthesized using a mixture of 250 mg (-)-epicatechin,
500 mgK2CO3 and 1 ml methyl iodide in20 mlacetone,
which was placed in an ultrasonic bath for 2.5 h.
The 30-O-methylated conjugates were purified by
semi-preparative HPLC and the positions of the methyl
groups were confirmed as described by Donovan et al.
(1999). The erythrocyte hemolysis was conducted
according to methods previously described (Zhu et al.
2002). Briefly, 1 ml of the erythrocyte suspension was
mixed with 1 ml of PBS solution containing varying
amounts of cocoa flavonoids and 30-O-methyl epica-
techin (7.5–60mM). About 1 ml of 200 mM AAPH in
PBS was then added to the mixture. The reaction
mixture was shaken gently while being incubated at
378C for 3 h. After incubation, the reaction mixture was
diluted with 8 vol of PBS and centrifuged at 3,000 £ g
for 5 min. The absorbance (A) of the supernatant
fraction at 540 nm was recorded in a Beckman DU 640
spectrophotometer. Percent inhibition was calculated
as described before (Zhu et al. 2002). L-Ascorbic acid
was used as a positive control (2.5–20mM).
HPLC analysis of epicatechin and catechin
Plasma samples were extracted as previously described
by Holt et al. (2002). After first treating the plasma
with a mixed solution of b-glucuronidase and sulfatase
(Type HP-2, from Helix pomatia; Sigma Chemical,
St. Louis, MO) to hydrolyze glucuronide, sulfate or
sulfoglucuronide conjugates to the nonconjugated free
form of epicatechin and catechin. The resulting
solution was filtered with a 0.22mm Millipore Ultra-
free-MC low binding Durapore centrifugal filter
(Millipore, Bedford, MA). 50ml of the filtered
solution was analyzed for catechin, epicatechin and
procyanidins by reversed-phase HPLC with coulo-
metric multiple-array detection.
Chromatography was carried out as described by
Holt et al. (2002) using a HP 1100 HPLC system
equipped with Chemstation software and a quaternary
pump (Hewlett Packard, Wilmington, DE), and an
ESA CoulArray 5600 coulometric electrochemical
array detector (ESA, Chelmsford, MA). Epicatechin
and catechin peak identification at þ150 mV was
based on co-elution with authentic standards and
quantified using external standards.
Statistics
Data were analyzed using analysis of variance
(ANOVA). Between treatment means were compared
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by independent t-test. The significance level was set at
0.05, and analysis was performed using routines
available in Statview for Windows (v 5.0.1. SAS, Cary,
NC). Results are expressed as means ^ SEM.
Results and discussion
Erythrocytes contain high concentrations of polyunsa-
turated fatty acids, molecular oxygen and ferrous ions
in the ligand state. Hence, it might be expected that
erythrocytes would be highly vulnerable to oxidative
stress. However, these cells possess an efficient
antioxidant system that renders them exceptionally
resistant to peroxidation when radicals are produced
within the cell (Niki et al. 1988, Miki et al. 1987). The
present work investigated the peroxidability of
the erythrocyte membrane, in which free radicals
were generated by an exogenous source. The peroxida-
tion of erythrocyte membranes can be studied with a
variety of agents, including hydrogen peroxide, dialuric
acid, xanthine oxidase and organic hydroperoxides
(Zhu et al. 2002, Miki et al. 1987), but AAPH offers
some specific advantages. Azo compounds, such as
AAPH, generate free radicals by their unimolecular
thermal decomposition in the aqueous region, and
these radicals quickly react with oxygen, producing
peroxyl radicals that are able to attack the erythrocyte
membrane. The rate of generation of free radicals can
be controlled and measured by adjusting the
concentration of the initiator. Further, the hemolysis
induced by AAPH provides a model for studying
oxidative membrane damage, when generation of free
oxygen radicals is initiated extracellularly (Zhu et al.
2002, Miki et al. 1987).
An example of the time-dependent rate of AAPH
induced erythrocyte hemolysis is given in Figure 2.
Sigmoid curves were obtained allowing for the
calculation of several quantitative parameters.
A simple index for comparing the relative response
to peroxidative stress is the time required to achieve
50% hemolysis (A). Another index is lag time (B),
defined as the interval (min) between the intercept of
the linear least-square slope of the curve with the
initial absorbance. This reflects the capacity of the cell
to buffer peroxyl radicals. The maximum amount of
hemolysis (C) and the time necessary to reach this (D)
were also obtained (Sugiyama et al. 1993).
The present study investigated the susceptibility of
human erythrocytes to peroxidation after the con-
sumption of a flavonoid-rich cocoa beverage. A typical
example of the time-dependent erythrocyte hemolysis
curves from one subject who consumed 0.25 g/kg BW
of the cocoa beverage is depicted in Figure 2 (Table I
gives the means for all the subjects). All three doses of
the beverages were effective in protecting against
hemolysis. We observed that within 1 h after the
subjects consumed the medium dose of cocoa
beverage (0.375 g/kg BW), the time necessary for
peroxyl radicals to hemolyze half of the erythro-
cytes (Hem 50) increased from 100 ^ 4.6 to
120.7 ^ 4.3 min. When subjects were given the
lower (0.25 g/kg BW) and higher (0.50 g/kg BW)
cocoa doses, Hem 50 was significantly increased to
106.5 ^ 3.2 and 108.8 ^ 3.1 min, respectively, 2 h
after cocoa consumption. A similar pattern was found
for changes in the lag time and maximum hemolysis
(see Table I). Compared to the low (0.25 g/kg) and
high (0.5 g/kg BW), the medium dose (0.375 g/kg
BW) exhibited faster and stronger inhibition in almost
all parameters. The reasons for this inconsistency are
obscure, but may result from individual differences;
i.e. the fact that sigmoid hemolysis curves vary across
subjects. Unpublished data in our laboratory shows
that the medium dose has a stronger inhibitory effect
upon epinephrine-stimulated platelet activation than
either low or high doses. The failure of the ex vivo
hemolysis to exhibit dose-dependent effects in vitro is
not known. It may be that the ex vivo hemolysis
inhibition gradually saturates. Another equally plaus-
ible supposition is that the consumption of 3 doses of
cocoa powder increases caffeine consumption in a
dose-dependent manner. It has been reported
(Lecomte and Boivin 1981) that caffeine and other
methylxanthines inhibit human erythrocyte phos-
phatidyl inositol kinase, thymidine kinase and
cAMP-independent protein kinase, thus inhibiting
protein phosphorylation. As spectrin phosphorylation
is necessary for the equilibrium of the erythrocyte
cytoskeleton, the caffeine content in the high dose of
cocoa could have led to the instability of the
erythrocyte membrane, resulting in hemolysis.
It has been well documented that flavonoids
from different sources including grape seed
extract (Carini et al. 2000, Zou et al. 2001), cocoa
Figure 2. Time-dependent hemolysis of erythrocytes from one
subject at baseline, and 1, 2, 4 and 8 h after receiving 0.25 g/kg BW
of a cocoa beverage. The reaction was induced by 200 mM AAPH.
Arrows indicate the parameters that were calculated: (A) 50%
hemolysis; (B) lag time; (C) maximal hemolysis; (D) time at which
maximum hemolysis is reached.
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(Zhu et al. 2002), green tea (Zhang et al. 1997) and
pine bark extract (Sharma et al. 2003) can offer
protection against AAPH-induced and UVB-induced
erythrocyte damage in vitro. The cocoa flavanols
(epicatechin, catechin), Dimer B2 and 30-O-methyl
epicatechin all provided protective effects ( p , 0.001)
against free radical-induced hemolysis in a dose-
dependent manner (2.5mM–20mM). The level of
protection exceeded that of ascorbic acid (Figure 3).
It is interesting to note that both epicatechin
and catechin can significantly protect human erythro-
cytes from free radical-induced hemolysis, even at
a concentration as low as 2.5mM. While the
concentrations of epicatechin and catechin in human
plasma reached 2.86mM and 210 nm, respectively
(Figure 4), after the consumption of a high dose of
cocoa (0.50 g/kg BW), these were sufficient to protect
human blood against in vivo oxidative damage. Also,
the other bioavailable forms of flavonoids (such as
Dimer B2) (Baba et al. 2002, Holt et al. 2002, Zhu
et al. 2002) and metabolites (such as 30-O-methyl
epicatechin) (Day et al. 1998, Kuhnle et al. 2000)
known to be present after cocoa consumption would
also contribute to this protective activity of cocoa.
Previous studies reported that procyanidins have a
stronger protective effect than their monomeric units
in vitro (Lotito et al. 2000, Arteel et al. 1999,
Takahashi et al. 1999, Zhu et al. 2002). This is
different from the present result in which epicatechin
demonstrated stronger protection than Dimer B2.
The reason for this inconsistency is unknown. One of
the possible reasons is that in the present in vitro study,
individual compounds were used, while in the
previous studies, a mixture of monomers (epicatechin
and catechin) and a mixture of dimers [(Dimer B2 and
Dimer B5 (epicatechin-(4b . 6)-epicatechin)] were
compared (Zhu et al. 2002). Preliminary work in our
lab shows that Dimer B5 has more antioxidant activity
than Dimer B2 (unpublished data).
The protective effect of flavonoids toward the
erythrocyte membrane has been attributed to their
antioxidant capacities. But the results from in vitro
studies cannot be directly extrapolated to the human
situation because the flavonoids applied to those
systems are not, in general, the forms circulating in
vivo after absorption. Flavonoids are generally
modified on absorption in vivo, and recent studies
Table I. Parameters measured from the hemolysis curves of erythrocytes.
0 h 1 h 2 h 4 h 8 h
Hem 50 (min), control 100.0 ^ 6.5a,1 97.2 ^ 4.2a,1 95.1 ^ 5.6b,1 102.8 ^ 3.2a,1 101.1 ^ 4.2a,1
Low dose 100.0 ^ 4.1a,1 100.0 ^ 2.7a,1 106.5 ^ 3.2b,2 114.0 ^ 3.7c,2 120.3 ^ 4.2d,2
Medium dose 100.0 ^ 4.6a,1 120.7 ^ 4.3b,2 106.7 ^ 4.2c,2 116.5 ^ 3.2b,2 104.1 ^ 3.1c,1
High dose 100.0 ^ 3.4a,1 106.7 ^ 3.7b,1 108.8 ^ 3.1b,2 109.8 ^ 2.9b,2 105.3 ^ 2.1b,1
Lag Time (min), control 100.0 ^ 7.9a,1 97.0 ^ 7.8a,1 94.3 ^ 5.7b,1 95.7 ^ 5.7b,1 98.1 ^ 5.6a,1
Low dose 100.0 ^ 6.1a,1 99.3 ^ 4.9a,1 104.2 ^ 3.5b,2 103.6 ^ 3.1a,2 107.8 ^ 3.1b,2
Medium dose 100.0 ^ 4.1a,1 104.9 ^ 5.5b,2 102.3 ^ 5.6a,2 104.2 ^ 3.4b,2 101.5 ^ 4.1a,1
High dose 100.0 ^ 4.3a,1 101.5 ^ 3.3a,2 102.5 ^ 3.5a,2 103.2 ^ 3.0a,2 101.1 ^ 3.9a,1
Hem. max (%), control 100.0 ^ 4.7a,1 100.9 ^ 4.8a,1 102.1 ^ 2.0a,1 103.4 ^ 7.5a,1 103.6 ^ 4.4a,1
Low dose 100.0 ^ 3.1a,1 99.6 ^ 3.5a,1 96.9 ^ 2.0a,1 92.7 ^ 4.5b,1 89.2 ^ 2.1b,2
Medium dose 100.0 ^ 6.8a,1 88.2 ^ 2.5b,2 92.1 ^ 2.5b,2 87.9 ^ 2.8b,2 92.4 ^ 1.7b,2
High dose 100.0 ^ 3.6a,1 98.5 ^ 2.3a,1 89.1 ^ 4.2b,2 89.9 ^ 3.9b,2 99.1 ^ 2.3a,1
Time of max hemolysis (min), control 100.0 ^ 3.9a,1 91.2 ^ 3.8b,1 95.5 ^ 2.8b,1 102.5 ^ 4.3a,1 100.6 ^ 3.0a,1
Low dose 100.0 ^ 3.9a,1 101.2 ^ 4.1a,2 109.6 ^ 4.5b,2 114.3 ^ 3.0c,2 116.5 ^ 5.1c,2
Medium dose 100.0 ^ 2.7a,1 111.0 ^ 4.9b,2 101.9 ^ 4.1a,1 106.9 ^ 1.8c,1 105.3 ^ 4.3c,1
High dose 100.0 ^ 0.9a,1 110.4 ^ 3.1b,2 111.7 ^ 3.8b,1 108.1 ^ 4.0b,1 105.7 ^ 3.7b,1
a,b,c,d means in the same row with different superscripts differ significantly at p , 0.05.1,2 means for the different doses at each time point with
different superscripts differ significantly from their respective controls at p , 0.05. Data are expressed as mean ^ SEM of n ¼ 8.*Hem 50:
the time required to achieve 50% hemolysis; Lag time: the interval between the intercept of the linear least-square slope of the curve with the
initial absorbance; Hem. max (%): the maximum amount of hemolysis; Time of max hemolysis: the time necessary to reach the maximum
hemolysis; Low dose: 0.25 g/kg BWof a cocoa beverage; Medium dose: 0.375 g/kg BWof a cocoa beverage; High dose: 0.50 g/kg BWof a cocoa
beverage.
Figure 3. The protective effects of epicatechin (L-L), catechin
(A-A), Dimer B2 (S-S), and 30-O-methyl epicatechin (A-A),
expressed as percent inhibition of erythrocyte hemolysis. Ascorbic
acid (D-D) was used as a reference compound. Data are expressed as
means ^ SEM of n ¼ 5–6.
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have shown that they are extensively metabolized,
initially during transfer across the small intestine and
secondly by the liver, to a variety of conjugates and
metabolites. For example, absorption through the
small intestine promotes deglycosylation and glucuro-
nidation, as well as O-methylation of catechol-
containing phenolics (Day et al. 1998, Kuhnle et al.
2000). Because the catechol-containing flavonoid
structures are known to be powerful H-donating
antioxidants, we also studied the influence of catechol
methylation on the antioxidant activity of epicatechin,
in the form of 30-O-methyl epicatechin. We observed
that the individual flavonoids and 30-O-methyl
epicatechin provided similar protection against
erythrocyte hemolysis in vitro at concentrations
ranging from 2.5 to 20mM (Figure 3). It is interesting
to note that both epicatechin, and its metabolite, 30-O-
methyl epicatechin, can significantly protect human
erythrocytes from free radical-induced hemolysis,
even at a concentration as low as 2.5mM.
The mechanism(s) by which cocoa flavanols and
procyanidins protect erythrocytes from hemolysis have
not been characterized. It is possible that the
consumption of cocoa spares the use of other
antioxidants (e.g. ascorbic acid, a-tocopherol), and
these in turn afford protection to the cell membrane.
Flavonoids have been shown to spare, maintain, or
regenerate a-tocopherol and other antioxidants by
donating hydrogen to a-tocopherol radicals (Zhu et al.
1999). Another possibility is that flavonoids stabilize
the erythrocyte membrane by suppressing the loss of
glycolytic intermediates, such as intracellular ATP
(adenosine triphosphate) and 2,3-DPG (2,3-diphos-
phoglycerate) (Moriguchi et al. 2001). Bombardelli
et al. (1989) has reported specific localization of
procyanidins within the phospholipid bilayer. This
suggests the possibility of a preferential binding with
membrane phospholipids, very likely via a complex-
ation mechanism, via electrostatic interactions
between the nucleophilic phenol groups of oligomeric
catechins and the cationic polar heads of phospho-
lipids. This interpretation is supported by NMR
studies with procyanidins and other polyphenols and
soybean phosphatidylcholine (Bombardelli et al.
1989). Recently, Verstraeten et al. (2003) reported
that flavanols and procyanidins interact with mem-
brane phospholipids through hydrogen bonding to the
polar head groups of phospholipids. As a consequence,
these compounds can accumulate at the membrane
surface, both outside and inside the cell. Through this
kind of interaction, flavanols and procyanidins might
act to maintain membrane integrity by reducing the
access of deleterious molecules to the hydrophobic
region of the bilayer, including those that can affect
membrane rheology as well as those that induce
oxidative damage to the membrane components.
In summary, the consumption of a flavonoid-rich
cocoa can be associated with a reduction in the rate of
erythrocyte hemolysis in human adults. In erythro-
cytes obtained from healthy adult subjects, lag time
and maximal hemolysis were increased for at least 2 h
following consumption of the beverage. In vitro tests
indicate that cocoa flavanols and metabolites possess
strong antioxidative activity, resulting in a significant
decrease in erythrocyte hemolysis. Additional research
is needed to characterize the membrane binding and
membrane action of catechin, epicatechin and the
procyanidins.
Figure 4. Changes in plasma concentrations of (-)-epicatechin (EC), (þ)-catechin (CT), 30-O-methyl epicatechin and (-)-epicatechin-
(4b . 8)-epicatechin (Dimer B2) in human subjects after they consumed low-dose (0.25 g/kg BW, W-W), medium dose (0.375 g/kg BW, A-A),
and high dose (0.50 g/kg BW, D-D) flavonoid-rich cocoa beverage. Data are expressed as means ^ SEM of n ¼ 8.
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